Fresenius Kabi Targets Treatment of Certain Seizures with Launch of Generic Lacosamide Injection, USP Read more
Dupixent (dupilumab) approved by European Commission as the first and only targeted medicine indicated for prurigo nodularis Read more
EISAI AND WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS ENTER INTO COMPREHENSIVE RESEARCH COLLABORATION AGREEMENT AIMING TO CREATE NEW THERAPIES FOR NEURODEGENERATIVE DISEASES Read more
Psyence and Filament Health Announce Worldwide Licensing Agreement of Psilocybin Capsule for Palliative Care Read more
Innovent and LG Chem Announce Strategic Collaboration for Tigulixostat, a Novel Non-Purine Xanthine Oxidase Inhibitor for the Treatment of Gout Disease Read more
Harrow Enters into Agreement to Acquire Exclusive U.S. Rights to ILEVRO, NEVANAC, VIGAMOX, MAXIDEX, and TRIESENCE Read more